APA

Roger A., Finet A., Boru B., Beauchet A., Mazeron J., Otzmeguine Y., Blom A., Longvert C., de Maleissye M., Fort M., Funck-Brentano E. & Saiag P.Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients. : Oncoimmunology.

Chicago

Roger Anissa, Finet Adeline, Boru Blandine, Beauchet Alain, Mazeron Jean-Jacques, Otzmeguine Yves, Blom Astrid, Longvert Christine, de Maleissye Marie-Florence, Fort Magali, Funck-Brentano Elisa and Saiag Philippe.Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients. : Oncoimmunology.

Harvard

Roger A., Finet A., Boru B., Beauchet A., Mazeron J., Otzmeguine Y., Blom A., Longvert C., de Maleissye M., Fort M., Funck-Brentano E. and Saiag P.Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients. : Oncoimmunology.

MLA

Roger Anissa, Finet Adeline, Boru Blandine, Beauchet Alain, Mazeron Jean-Jacques, Otzmeguine Yves, Blom Astrid, Longvert Christine, de Maleissye Marie-Florence, Fort Magali, Funck-Brentano Elisa and Saiag Philippe.: Oncoimmunology. .